News

Ferrer also announced it is collaborating with Ildong Pharmaceuticals, Korea. Ergomed is working with Ferrer as the clinical development organization to conduct the multicenter, multinational, randomized Phase IIa

The treatments will deliver cancer-fighting agents based on constituents of Cannabis (marijuana) that are known as cannabinoids. In developing cancer treatments utilizing the Cell-in-a-Box live-cell encapsulation technology, living

Providence Portland Medical Center filed the IND in late December 2013. Providence Portland Medical Center’s Earle A. Chiles Research Institute (EACRI) will conduct the Phase IB study under

About 70 million people in Africa are affected by sleeping sickness, which is spread by the bite of the tsetse fly and is prevalent in west and central

When compared to placebo, lenvatinib showed statistically significant improvement in progression free survival (PFS) in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). According to the preliminary safety analysis,

Results are of the PEARL-II, PEARL-III, PEARL-IV and TURQUOISE-II studies, which are part of the six Phase III registrational studies being conducted by AbbVie to treat genotype 1

Fisher Scientific, which is the premier customer channel brand within Thermo Fisher Scientific, has a good position in the life sciences market and represents broad customer reach. Under

The patent is directed to compositions that include the chemical structure and to 500mg to 600mg unit doses of ferumoxytol and it is listed in Approved Drug Products

Under the deal, DSP will get select development and commercialization rights in Japan and North America to jointly discovered drugs in exchange for $10m upfront and $40m payment